You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AXL

Showing 1 - 25 of 201
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Circulating Tumor Cell Trial in Montpellier (Detection of

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Detection of circulating tumor cells expressing Axl: CTC-AXL(+)
  • Montpellier, France
    CHU Montpellier
Jul 1, 2022

Brain and CNS Tumors Trial in United States (BGB 324 (before surgery), BGB 324 (after surgery))

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • BGB 324 (before surgery)
  • BGB 324 (after surgery)
  • Birmingham, Alabama
  • +5 more
Dec 1, 2022

Lung Cancer, Cancer, Immunotherapy Trial in Guangzhou (CAR-T cells targeting PSCA, MUC1, TGFß, HER2, Mesothelin, Lewis-Y, GPC3,

Recruiting
  • Lung Cancer
  • +3 more
  • CAR-T cells targeting PSCA, MUC1, TGFβ, HER2, Mesothelin, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2, or B7-H3
  • Guangzhou, Guangdong, China
  • +1 more
Nov 26, 2021

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
Has Results
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer Trial (Q702, Pembrolizumab)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • (no location specified)
Jun 27, 2022

Cancer of Pancreas Trial in Dallas (Bemcentinib, Nab-paclitaxel, Gemcitabine)

Terminated
  • Cancer of Pancreas
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Sep 26, 2022

Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic Trial in Canada, United States (SLC-391, Pembrolizumab)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • +2 more
  • Indianapolis, Indiana
  • +8 more
May 5, 2023

Migraine Trial in Argentina, United States (Eptinezumab)

Recruiting
  • Migraine
  • Loxahatchee Groves, Florida
  • +3 more
Aug 17, 2022

Chronic Lymphocytic Leukemia, CLL, SLL Trial in United States (TP-0903, TP-0903 and ibrutinib combination therapy)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • TP-0903
  • TP-0903 and ibrutinib combination therapy
  • Phoenix, Arizona
  • +5 more
Apr 4, 2022

Colitis Ulcerative Trial in Worldwide (SAR443122, Placebo)

Recruiting
  • Colitis Ulcerative
  • Los Alamitos, California
  • +5 more
Jan 20, 2023

Non-Small-Cell Lung Cancer Trial in Hong Kong, Taiwan, United States (CAB-AXL-ADC, PD-1 inhibitor)

Recruiting
  • Non-Small-Cell Lung Cancer
  • CAB-AXL-ADC
  • PD-1 inhibitor
  • Duarte, California
  • +34 more
Jul 11, 2022

Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic

Unknown status
  • Hemodialysis Complication
    • Shanghai, Shanghai, China
      Department of Nephrology & Rheumatology, Shanghai Tenth People's
    Nov 1, 2020

    Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Los Angeles, Chicago, Morristown (Q702)

    Recruiting
    • Solid Tumor
    • +2 more
    • Los Angeles, California
    • +3 more
    Jul 29, 2021

    Advanced Solid Tumors, EGFR Positive NSCLC, Colorectal Carcinoma Trial in United States (TP-0903)

    Active, not recruiting
    • Advanced Solid Tumors
    • +4 more
    • Phoenix, Arizona
    • +15 more
    Apr 4, 2022

    Chronic Migraine in Children Trial in Worldwide (Eptinezumab, Placebo)

    Recruiting
    • Chronic Migraine in Children
    • Hialeah, Florida
    • +15 more
    Aug 17, 2022

    Liver Cancer, Lung Cancer, Breast Cancer Trial in Guangzhou (TILs and CAR-TILs targeting HER2, Mesothelin, PSCA, MUC1, Lewis-Y,

    Recruiting
    • Liver Cancer
    • +7 more
    • TILs and CAR-TILs targeting HER2, Mesothelin, PSCA, MUC1, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2/6, ROR1, GD1, or B7-H3
    • Guangzhou, China
      Second Affiliated Hospital of Guangzhou Medical University
    Apr 9, 2021

    Juvenile Idiopathic Arthritis Trial in Worldwide (Sarilumab SAR153191 (REGN88))

    Recruiting
    • Juvenile Idiopathic Arthritis
    • Sarilumab SAR153191 (REGN88)
    • Tucumán, Argentina
    • +29 more
    Jan 9, 2023

    Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic Trial in Worldwide (HZN-825 BID, Placebo, HZN-825 QD)

    Recruiting
    • Diffuse Cutaneous Systemic Sclerosis
    • Sclerosis, Systemic
    • HZN-825 BID
    • +2 more
    • Phoenix, Arizona
    • +48 more
    Jun 21, 2022

    Systemic Lupus Erythematosus Trial in Worldwide (Daxdilimab)

    Enrolling by invitation
    • Systemic Lupus Erythematosus
    • Daxdilimab
    • Upland, California
    • +58 more
    Jun 20, 2022

    Soft Contact Lens Trial in Taichung (soft contact lens)

    Completed
    • Soft Contact Lens
    • soft contact lens
    • Taichung, Taiwan
      Chung Shan Medical University Hospital
    Feb 16, 2023

    Sjögren's Syndrome Trial in Worldwide (SAR441344, Placebo)

    Recruiting
    • Sjögren's Syndrome
    • DeBary, Florida
    • +38 more
    Dec 29, 2022

    Pulmonary Arterial Hypertension Trial in Worldwide (Treprostinil Palmitil, Placebo)

    Recruiting
    • Pulmonary Arterial Hypertension
    • Treprostinil Palmitil
    • Placebo
    • West Hollywood, California
    • +43 more
    Jul 21, 2022

    Acute Myeloid Leukemia, High-risk Myelodysplastic Syndrome, Low-risk Myelodysplastic Syndrome Trial in France, Germany,

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • Nantes, Nantes Cedex 1, France
    • +7 more
    Dec 20, 2021

    Cold Urticaria Trial in Worldwide (Dupilumab SAR231893, Placebo, Non sedating H1-antihistamine)

    Active, not recruiting
    • Cold Urticaria
    • Dupilumab SAR231893
    • +2 more
    • San Diego, California
    • +34 more
    Nov 15, 2022

    Juvenile Idiopathic Arthritis Trial in Worldwide (Sarilumab)

    Active, not recruiting
    • Juvenile Idiopathic Arthritis
    • Los Angeles, California
    • +34 more
    May 10, 2022